Meeting
2019 Genitourinary Cancers Symposium
The effect of the timing of biochemical failure after external beam radiotherapy or low-dose-rate brachytherapy for definitive prostate cancer treatment.
Authors
Jay P. Ciezki
Cleveland Clinic, Cleveland, OH
Jay P. Ciezki , Chandana A. Reddy , Omar Y. Mian , Rahul D. Tendulkar , James Ulchaker , Kenneth Angermeier , Steven Campbell , Andrew J. Stephenson , Mark Stovsky , Eric A. Klein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 28)
DOI
10.1200/JCO.2019.37.7_suppl.28
Abstract #
28
Poster Bd #
B16
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Clinical outcomes following biochemical recurrence among patients with Gleason score 9-10 prostate adenocarcinoma.
First Author: Kiri A Sandler
Poster
2017 ASCO Annual Meeting
Ten-year overall and prostate cancer (PCa)-specific mortality in high-risk patients after high-dose-rate brachytherapy combined with external beam radiation therapy (HDR-BT/EBRT) compared with EBRT alone.
First Author: Trude Baastad Wedde
Poster
2015 Genitourinary Cancers Symposium
Impact of timing of biochemical failure on the eventual development of clinical failure after definitive treatment with brachytherapy or external beam radiotherapy for prostate cancer.
First Author: Jay P. Ciezki
Poster
2024 ASCO Genitourinary Cancers Symposium
Long-term outcomes for patients with radiorecurrent prostate cancer treated with salvage combination IMRT and brachytherapy.
First Author: Michael J. Dattoli